Axontherapix

ACTIVITY A biotechnology company focused on the development of a new treatment for Parkinson’s Disease, based on adult stem cells from the carotid body.
TECHNOLOGY

Stem cells from the carotid body.
The human carotid body has a population of neuronal precursors (stem cells) that produce dopamine and glial cell line-derived neurotrophic factor (GDNF).
PRODUCTS/SERVICES

ATX-101: Product based on stem cells obtained from the carotid body.